Chronic Graft vs. Host Disease

13 clinical trials · Condition

Record	Firm	Date
Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib (NCT05095649)	Fundación Pública Andaluza para la gestión de la Investigación en Sevilla	2022-03-24
A Study to Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants (NCT04852692)	Janssen Korea, Ltd., Korea	2021-06-21
Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-host-Disease (NCT03683498)	Fundación Pública Andaluza para la gestión de la Investigación en Sevilla	2018-09-25
Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation (NCT02759731)	National Cancer Institute (NCI)	2016-11-01
Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation (NCT02669251)	National Cancer Institute (NCI)	2016-04-28
Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD (NCT02322190)	National Cancer Institute (NCI)	2014-12-20
Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease (NCT02067832)	University of British Columbia	2013-11-01
Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease (NCT01221766)	Dana-Farber Cancer Institute	2010-09-01
Campath in Chronic GVHD (NCT00495755)	Dana-Farber Cancer Institute	2007-07-01
Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease (NCT00092235)	National Cancer Institute (NCI)	2004-10-26
Expanded Access of Axatilimab to Treat a Single Patient With Chronic Graft Versus Host Disease (GVHD) (NCT05544032)	Incyte Corporation

Track Chronic Graft vs. Host Disease automatically

Every clearance here is in the API, with alerts when new ones post.